| Date Filed | Type | Description |
| 08/04/2023 |
4
| Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,422 shares
@ $1.02, valued at
$1.5k
Exercised 4,750 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 79,000 options to buy
@ $0.73, valued at
$57.7k
Granted 26,000 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,785 shares
@ $1.36, valued at
$2.4k
Exercised 6,900 restricted stock units
@ $0 |
|
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Guerin Mark Patrick (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 62,100 options to buy
@ $1.82, valued at
$113k
Granted 20,700 restricted stock units
@ $0 |
|
| 08/04/2021 |
4
| Guerin Mark Patrick (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 42,750 options to buy
@ $5.19, valued at
$221.9k
Granted 14,250 restricted stock units
@ $0 |
|
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2020 |
4
| Guerin Mark Patrick (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Bought 21,000 shares
@ $0.36, valued at
$7.6k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/26/2019 |
4
| Guerin Mark Patrick (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Bought 87,500 shares
@ $0.2, valued at
$17.5k
Bought 87,500 options to buy
@ $0.2, valued at
$17.5k
|
|
| 07/30/2018 |
4
| Guerin Mark Patrick (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 384,950 options to buy
@ $0.46, valued at
$177.1k
|
|
| 01/05/2018 |
4
| Guerin Mark Patrick (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 31,024 options to buy
@ $1.5, valued at
$46.5k
|
|
| 04/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/01/2016 |
4
| Guerin Mark Patrick (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.24, valued at
$32.4k
Granted 5,000 options to buy
@ $3.24, valued at
$16.2k
|
|
| 08/10/2016 |
4
| Guerin Mark Patrick (Chief Accounting Officer) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Exercised (in-or-at-the-money) 3,666 shares
@ $4.1, valued at
$15k
Exercised (in-or-at-the-money) 90 rights
@ $4.1, valued at
$369
Exercised (in-or-at-the-money) 2,749 warrants
@ $4.92, valued at
$13.5k
|
|